Age Related Macular Degeneration News and Research

RSS

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye.

3 Oct 2016

Research findings offer promising treatment target for blinding diseases

New research published in Cell Reports identifies a potential treatment target for blinding diseases such as retinitis pigmentosa and advanced dry age-related macular degeneration.

28 Sep 2016

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.

2 Sep 2016

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

In microseconds, every light ray that enters the eye triggers an explosion of coordinated cellular events.

29 Aug 2016

RPB continues research initiative to address urgent needs in treating low vision

Research to Prevent Blindness is continuing its research initiative to address urgent needs in understanding and treating low vision.

28 Aug 2016

Research opens way towards making promising advances in retinal prostheses

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear.

25 Aug 2016

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases.

4 Aug 2016

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection.

27 Jul 2016

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.

21 Jul 2016

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

According to the World Health Organization, approximately 285 million people are estimated to be visually impaired worldwide. Age-related macular degeneration (AMD) is a major cause of vision loss in aging populations.

11 Jul 2016

Buck researchers find new way for possible treatment of AMD

Buck researchers boosted the potency of a broccoli-related compound by ten times and identified it as a possible treatment for age-related macular degeneration (AMD), the leading cause of vision loss affecting more than 10 million older Americans.

7 Jul 2016

New research could pave way for improving retinal implants

Engineers and neuroscientists at the University of Sheffield have demonstrated for the first time that the cells in the retina carry out key processing tasks. This could pave the way for improving retinal implants and therefore the sight of thousands of people suffering from retinal disorders.

29 Jun 2016

Eye donations: what stops people? An interview with Rory Passmore

Despite a shortage of corneas for transplant purposes, our new research reveals that eyes are the one body part we are least likely to donate.

27 Jun 2016

NIH-funded study finds visual impairment, blindness may double by 2050

With the youngest of the baby boomers hitting 65 by 2029, the number of people with visual impairment or blindness in the United States is expected to double to more than 8 million by 2050, according to projections based on the most recent census data and from studies funded by the National Eye Institute, part of the National Institutes of Health.

23 May 2016

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

The University of Southern California Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD) in the National Eye Institute-funded "Los Angeles Latino Eye Study." The study, published in JAMA Ophthalmology, is the first to analyze the risk and prevalence of early and late stage AMD and its impact on quality of life for older Latinos.

4 May 2016

Report: Protecting eyes from UV exposure not high priority for Americans

Three-quarters of Americans are concerned about potential eye problems from the sun's ultraviolet rays, yet only 31 percent protect their eyes with sunglasses or other UV-protective eyewear every time they go outside, according to a new nationwide survey released today. The report by The Vision Council, based on a survey of more than 10,000 adults, finds 34 percent of adults have experienced symptoms of prolonged UV exposure, such as eye irritation, trouble seeing, and red or swollen eyes.

4 May 2016

Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Researchers have safely transplanted stem cells derived from a patient's skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.

4 May 2016

Artificial and natural vision successfully integrated for first time in humans

Scientists have successfully implanted a prosthesis that restores some central vision in patients with only limited peripheral vision remaining to them - the first time artificial and natural vision has ever been integrated in humans. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash.

4 May 2016

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read standard print, after five years of treatment with anti-VEGF drugs that are injected into the eye. The authors of the study, funded by the National Eye Institute (NEI) at the National Institutes of Health, say those outcomes would have been unimaginable about 10 years ago, prior to the drugs' availability.

3 May 2016

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.

2 May 2016

Age Related Macular Degeneration News and Research

UEF research shows retinal changes may be detected earlier than brain changes

Research findings offer promising treatment target for blinding diseases

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

RPB continues research initiative to address urgent needs in treating low vision

Research opens way towards making promising advances in retinal prostheses

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Researchers find potential way for delivering gene therapy to treat eye diseases

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

Nanoscope researchers develop novel VMCO and NOD platform for patients with vision loss

Buck researchers find new way for possible treatment of AMD

New research could pave way for improving retinal implants

Eye donations: what stops people? An interview with Rory Passmore

NIH-funded study finds visual impairment, blindness may double by 2050

LALES study analyzes risk, prevalence of early and late stage AMD among Latinos

Report: Protecting eyes from UV exposure not high priority for Americans

Researchers safely transplant stem cells from patient's skin to the eye to restore vision

Artificial and natural vision successfully integrated for first time in humans

NEI-funded study analyzes outcomes of anti-VEGF therapy for AMD

NEI to discuss research advances in regenerative medicine for eye disease at ARVO 2016

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News